APOGEPHA International
APOGEPHA belongs with the development of a drug for the treatment of urinary incontinence (active ingredient: propiverine) to the major companies in the global antimuscarinic market.
APOGEPHA is an independent, German, medium-sized pharmaceutical company specialising in the field of urology.
We developed propiverine, one of the leading medicines for the treatment of overactive bladder and neurogenic detrusor overactivity in adults and children.
Various dosages and formulations of propiverine are available under the trademarks Mictonorm®, Mictoryl® and Detrunorm®.
The patent of our unique once daily formulation of propiverine is approved in most countries. Currently we have marketing and distribution partners in more than twenty countries, with a focus on Europe and Asia.
We are looking for out-licensing partners with expertise in the urology sector in all promising markets.
Login International
User login
Enter your username and password here in order to log in on the website
Countries and Products
Egypt
Mictonorm® XL 30 mg
Mictonorm® 15 mg
Belgium
Mictonorm Uno® 30 mg
Mictonorm® 15 mg
Mictonet® 5 mg
Croatia
Detrunorm® 15 mg
Czech Republic
Mictonorm Uno® 30 mg
Mictonorm Uno® 45 mg
Mictonorm® 15 mg
Mictonetten® 5 mg
Rapidnorm®
Germany
Mictonorm Uno® 30 mg
Mictonorm Uno® 45 mg
Mictonorm® FT 15 mg
Mictonetten® 5 mg
Mictonetten® 10 mg
Indonesia
Mictonorm® 15 mg
Ireland
Detrunorm® XL 30 mg
Detrunorm® XL 45 mg
Italy
Mictonorm® 30 mg
Mictonorm® 45 mg
Mictonorm® 15 mg
Japan
Mictonorm®
Lebanon
Mictonorm® XL 30 mg
Mictonorm® 15 mg
Malaysia
Mictonorm® 15 mg
Philippines
Mictonorm® 15 mg
Portugal
Mictonorm® OD 30 mg
Mictonorm® OD 45 mg
Slovakia
Mictonorm® 15 mg
Slovenia
Detrunorm® 15 mg
South Africa
Detrunorm® XL 30 mg
Detrunorm® 15 mg
Turkey
Mictonorm® SR 30 mg
Mictonorm® 15 mg
United Arab Emirates
Mictonorm® 15 mg
Venezuela
Mictonorm® 15 mg
United Kingdom
Detrunorm® XL 30 mg
Detrunorm® XL 45 mg
Detrunorm® 15 mg
Singapore
Mictonorm® 15 mg
China
Mictonorm® 30 mg
Canada
Mictoryl® 30 mg
Mictoryl® 45 mg
Mictoryl® Pediatric 5 mg
Spain
Mictonorm® 30 mg
Namibia
Detrunorm® XL 30 mg
Detrunorm® 15 mg
Egypt
Mictonorm® XL 30 mg
Mictonorm® 15 mg
Belgium
Mictonorm Uno® 30 mg
Mictonorm® 15 mg
Mictonet® 5 mg
Croatia
Detrunorm® 15 mg
Czech Republic
Mictonorm Uno® 30 mg
Mictonorm Uno® 45 mg
Mictonorm® 15 mg
Mictonetten® 5 mg
Rapidnorm®
Germany
Mictonorm Uno® 30 mg
Mictonorm Uno® 45 mg
Mictonorm® FT 15 mg
Mictonetten® 5 mg
Mictonetten® 10 mg
Indonesia
Mictonorm® 15 mg
Ireland
Detrunorm® XL 30 mg
Detrunorm® XL 45 mg
Italy
Mictonorm® 30 mg
Mictonorm® 45 mg
Mictonorm® 15 mg
Japan
Mictonorm®
Lebanon
Mictonorm® XL 30 mg
Mictonorm® 15 mg
Malaysia
Mictonorm® 15 mg
Philippines
Mictonorm® 15 mg
Portugal
Mictonorm® OD 30 mg
Mictonorm® OD 45 mg
Slovakia
Mictonorm® 15 mg
Slovenia
Detrunorm® 15 mg
South Africa
Detrunorm® XL 30 mg
Detrunorm® 15 mg
Turkey
Mictonorm® SR 30 mg
Mictonorm® 15 mg
United Arab Emirates
Mictonorm® 15 mg
Venezuela
Mictonorm® 15 mg
United Kingdom
Detrunorm® XL 30 mg
Detrunorm® XL 45 mg
Detrunorm® 15 mg
Singapore
Mictonorm® 15 mg
China
Mictonorm® 30 mg
Canada
Mictoryl® 30 mg
Mictoryl® 45 mg
Mictoryl® Pediatric 5 mg
Spain
Mictonorm® 30 mg
Namibia
Detrunorm® XL 30 mg
Detrunorm® 15 mg
- Product on the market
- Launch upcoming
- Under contract